Clinical Trial

Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. The TRADE-AIS Study

Study acronym: TRADE-AIS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to determine whether specific parameters measured by transcranial Doppler ultrasound (TCD) can predict clinical outcomes in patients with acute ischemic stroke (AIS). The primary objective is to evaluate the association between middle cerebral artery (MCA) flow velocities and short-term neurological improvement. Secondary outcomes include the presence of collateral flow and flow patterns in relation to functional recovery measured by NIHSS and modified Rankin Scale (mRS) scores.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-27; most recent amendment 2025-09-13.
Trial Details
NCT Number NCT07004790
Lead Sponsor Jose Ivan Rodriguez de Molina Serrano
Conditions Stroke
Enrollment 50 participants
Start Date 2026-08-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-16